Skip to main content
Top
Published in: Neurotherapeutics 2/2013

01-04-2013 | Review

Genetic Counseling in Mitochondrial Disease

Authors: Jodie M. Vento, Belen Pappa

Published in: Neurotherapeutics | Issue 2/2013

Login to get access

Abstract

Mitochondrial diseases are a genetically and clinically diverse group of disorders that arise as a result of dysfunction of the mitochondria. Mitochondrial disorders can be caused by alterations in nuclear DNA and/or mitochondrial DNA. Although some mitochondrial syndromes have been described clearly in the literature many others present as challenging clinical cases with multisystemic involvement at variable ages of onset. Given the clinical variability and genetic heterogeneity of these conditions, patients and their families often experience a lengthy and complicated diagnostic process. The diagnostic journey may be characterized by heightened levels of uncertainty due to the delayed diagnosis and the absence of a clear prognosis, among other factors. Uncertainty surrounding issues of family planning and genetic testing may also affect the patient. The role of the genetic counselor is particularly important to help explain these complexities and support the patient and family’s ability to achieve effective coping strategies in dealing with increased levels of uncertainty.
Appendix
Available only for authorised users
Literature
1.
go back to reference Graham BH. Diagnostic challenges of mitochondrial disorders: complexities of two genomes. Methods Mol Biol 2012;837:35-46.PubMedCrossRef Graham BH. Diagnostic challenges of mitochondrial disorders: complexities of two genomes. Methods Mol Biol 2012;837:35-46.PubMedCrossRef
2.
go back to reference Stewart JL, Mishel MH. Uncertainty in childhood illness: A synthesis of the parent and child literature. Sch Inq Nurs Pract 2000;14:299-319.PubMed Stewart JL, Mishel MH. Uncertainty in childhood illness: A synthesis of the parent and child literature. Sch Inq Nurs Pract 2000;14:299-319.PubMed
3.
go back to reference Lipinski S, Lipinski MJ, Biesecker LG, Biesecker BB. Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling. Am J Med Genet C Semin Med Genet 2006;142C:232-240.PubMedCrossRef Lipinski S, Lipinski MJ, Biesecker LG, Biesecker BB. Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling. Am J Med Genet C Semin Med Genet 2006;142C:232-240.PubMedCrossRef
4.
go back to reference Baker MR, Fisher KM, Whittaker RG, Griffiths PG, Yu-Wai-Man P, Chinnery PF. Subclinical multisystem neurologic disease in “pure” OPA1 autosomal dominant optic atrophy. Neurology 2011;77: 1309-1312.PubMedCrossRef Baker MR, Fisher KM, Whittaker RG, Griffiths PG, Yu-Wai-Man P, Chinnery PF. Subclinical multisystem neurologic disease in “pure” OPA1 autosomal dominant optic atrophy. Neurology 2011;77: 1309-1312.PubMedCrossRef
5.
go back to reference Finsterer J. Leigh and Leigh-like syndrome in children and adults. Ped Neurology 2008;39:223-235.CrossRef Finsterer J. Leigh and Leigh-like syndrome in children and adults. Ped Neurology 2008;39:223-235.CrossRef
6.
go back to reference Lee IC, El-Hattab AW, Wang J, et al. SURF1-associated leigh syndrome: A case series and novel mutations. Hum Mutat 2012;33:1192-1200.PubMedCrossRef Lee IC, El-Hattab AW, Wang J, et al. SURF1-associated leigh syndrome: A case series and novel mutations. Hum Mutat 2012;33:1192-1200.PubMedCrossRef
7.
go back to reference Potluri P, Davila A, Ruiz-Pesini E, Mishmar D, O'Hearn S, Hancock S, et al. A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific neurodegenerative disease. Mol Genet Metab 2009;96:189-195.PubMedCrossRef Potluri P, Davila A, Ruiz-Pesini E, Mishmar D, O'Hearn S, Hancock S, et al. A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific neurodegenerative disease. Mol Genet Metab 2009;96:189-195.PubMedCrossRef
8.
go back to reference Mayr JA, Bodamer O, Haack TB, Zimmermann FA, Madignier F, Prokisch H, et al. Heterozygous mutation in the X chromosomal NDUFA1 gene in a girl with complex I deficiency. Mol Genet Metab 2011;103:358-361.PubMedCrossRef Mayr JA, Bodamer O, Haack TB, Zimmermann FA, Madignier F, Prokisch H, et al. Heterozygous mutation in the X chromosomal NDUFA1 gene in a girl with complex I deficiency. Mol Genet Metab 2011;103:358-361.PubMedCrossRef
9.
go back to reference Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008;1142:133-158.PubMedCrossRef Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008;1142:133-158.PubMedCrossRef
10.
go back to reference Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998;121:1889-1894.PubMedCrossRef Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998;121:1889-1894.PubMedCrossRef
11.
go back to reference Thorburn DR, Hans-Henrik DM. Mitochondrial disorders: Genetics, counseling, prenatal diagnosis and reproductive options. Am J Med Genet 2001;106:102-114.PubMedCrossRef Thorburn DR, Hans-Henrik DM. Mitochondrial disorders: Genetics, counseling, prenatal diagnosis and reproductive options. Am J Med Genet 2001;106:102-114.PubMedCrossRef
12.
go back to reference Haas RH, Parikh S, Falk MJ, et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007;120:1326-1333.PubMedCrossRef Haas RH, Parikh S, Falk MJ, et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007;120:1326-1333.PubMedCrossRef
13.
go back to reference Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008;94:16-37.PubMedCrossRef Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008;94:16-37.PubMedCrossRef
14.
go back to reference Bernier FP, Boneh A, Dennet X, Chow CW, Cleary MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406-1411.PubMedCrossRef Bernier FP, Boneh A, Dennet X, Chow CW, Cleary MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406-1411.PubMedCrossRef
15.
go back to reference Lewis C, Skirton H, Jones R. Living without a diagnosis: the parental experience. Genet Test Mol Biomarkers 2010;14:807-815.PubMedCrossRef Lewis C, Skirton H, Jones R. Living without a diagnosis: the parental experience. Genet Test Mol Biomarkers 2010;14:807-815.PubMedCrossRef
16.
go back to reference Graungaard AH, Skov L. Why do we need a diagnosis? A qualitative study of parents’ experiences, coping and needs, when the newborn child is severely disabled, Child Care Health Dev 2006;33: 296-307.CrossRef Graungaard AH, Skov L. Why do we need a diagnosis? A qualitative study of parents’ experiences, coping and needs, when the newborn child is severely disabled, Child Care Health Dev 2006;33: 296-307.CrossRef
17.
go back to reference Rosenthal ET, Biesecker LG, Biesecker BB. Parental attitudes toward a diagnosis in children with unidentified multiple congenital anomaly syndromes. Am J Med Genet 2001;103:106-114.PubMedCrossRef Rosenthal ET, Biesecker LG, Biesecker BB. Parental attitudes toward a diagnosis in children with unidentified multiple congenital anomaly syndromes. Am J Med Genet 2001;103:106-114.PubMedCrossRef
18.
go back to reference Jessup DJ, Stein RK. Uncertainty and its relationship to the psychological and social correlates of chronic illness in children. Soc Sci Med 1985;12:993-999.CrossRef Jessup DJ, Stein RK. Uncertainty and its relationship to the psychological and social correlates of chronic illness in children. Soc Sci Med 1985;12:993-999.CrossRef
19.
go back to reference Grootenhius MA, Last BF. Predictors of parental emotional adjustment to childhood cancer. Psychooncology 1997;6:115-128.CrossRef Grootenhius MA, Last BF. Predictors of parental emotional adjustment to childhood cancer. Psychooncology 1997;6:115-128.CrossRef
20.
go back to reference Clarke-Steffen L. A model of the family transition to living with childhood cancer. Cancer Pract 1993;1:285-292.PubMed Clarke-Steffen L. A model of the family transition to living with childhood cancer. Cancer Pract 1993;1:285-292.PubMed
21.
go back to reference Cohen MH. The unknown and the unknowable- Managing sustained uncertainty. West J Nurs Res 1993;15:77-96.PubMedCrossRef Cohen MH. The unknown and the unknowable- Managing sustained uncertainty. West J Nurs Res 1993;15:77-96.PubMedCrossRef
22.
go back to reference Rew L, Kaur M, McMillan A, Mackert M, Bonevac D. Systematic review of psychological benefits and harms of genetic testing, Issues Ment Health Nurs 2010;31:631-645.PubMedCrossRef Rew L, Kaur M, McMillan A, Mackert M, Bonevac D. Systematic review of psychological benefits and harms of genetic testing, Issues Ment Health Nurs 2010;31:631-645.PubMedCrossRef
23.
go back to reference Bredenoord AL, Dondorp W, Pennings G, De Die-Smulders CE, De Wert G. PGD to reduce reproductive risk: the case of mitochondrial DNA disorders. Hum Reprod 2008;23:2392-2401.PubMedCrossRef Bredenoord AL, Dondorp W, Pennings G, De Die-Smulders CE, De Wert G. PGD to reduce reproductive risk: the case of mitochondrial DNA disorders. Hum Reprod 2008;23:2392-2401.PubMedCrossRef
Metadata
Title
Genetic Counseling in Mitochondrial Disease
Authors
Jodie M. Vento
Belen Pappa
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 2/2013
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-012-0173-2

Other articles of this Issue 2/2013

Neurotherapeutics 2/2013 Go to the issue